Belleair Asset Management LLC Makes New $1.10 Million Investment in Cardinal Health, Inc. $CAH

Key Points

• Belleair Asset Management LLC bought a new stake of 5,354 shares of Cardinal Health (NYSE:CAH) in Q4, valued at approximately $1.10 million, making CAH 1.0% of its holdings and its 25th-largest position.
• Cardinal Health reported a Q3 non‑GAAP EPS beat ($3.17 vs. $2.79) and raised FY‑2026 guidance to $10.70–$10.80, but a revenue miss and a $184M pre‑tax goodwill impairment weighed on GAAP results and investor sentiment, leaving the stock down about 4.7%.
• Institutional interest is high—hedge funds own roughly 87.17% of the stock and large managers like Nordea added materially (645,436 shares, ~$133.7M), while analysts generally rate the stock a "Moderate Buy" with a consensus target near $244.33.

Belleair Asset Management LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 5,354 shares of the company's stock, valued at approximately $1,100,000. Cardinal Health makes up 1.0% of Belleair Asset Management LLC's holdings, making the stock its 25th largest holding.

Several other hedge funds also recently bought and sold shares of the stock. Strategy Asset Managers LLC acquired a new stake in shares of Cardinal Health during the 3rd quarter worth $775,000. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Cardinal Health by 15.3% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 37,833 shares of the company's stock worth $5,938,000 after buying an additional 5,030 shares during the period. Versor Investments LP purchased a new position in shares of Cardinal Health in the 3rd quarter worth $2,090,000. Atle Fund Management AB raised its position in shares of Cardinal Health by 13.1% in the 3rd quarter. Atle Fund Management AB now owns 30,297 shares of the company's stock worth $4,755,000 after buying an additional 3,500 shares during the period. Finally, Nordea Investment Management AB raised its position in shares of Cardinal Health by 328.3% in the 4th quarter. Nordea Investment Management AB now owns 645,436 shares of the company's stock worth $133,741,000 after buying an additional 494,731 shares during the period. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Down 4.7%

CAH opened at $193.21 on Friday. The firm has a market capitalization of $45.47 billion, a P/E ratio of 27.80, a P/E/G ratio of 1.31 and a beta of 0.64. The firm's 50 day moving average is $213.73 and its 200-day moving average is $205.46. Cardinal Health, Inc. has a 52-week low of $136.71 and a 52-week high of $233.60.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The company had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same quarter last year, the firm posted $2.35 earnings per share. The business's quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities analysts expect that Cardinal Health, Inc. will post 10.32 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st were given a dividend of $0.5107 per share. The ex-dividend date of this dividend was Wednesday, April 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.1%. Cardinal Health's dividend payout ratio (DPR) is presently 29.35%.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Zacks Research raised Cardinal Health from a "hold" rating to a "strong-buy" rating in a research report on Thursday, February 12th. Leerink Partners reaffirmed an "outperform" rating and issued a $275.00 target price on shares of Cardinal Health in a research report on Monday, March 9th. Robert W. Baird set a $252.00 price target on shares of Cardinal Health in a report on Friday, February 6th. William Blair initiated coverage on shares of Cardinal Health in a report on Tuesday. They issued an "outperform" rating on the stock. Finally, Mizuho raised their price target on shares of Cardinal Health from $222.00 to $235.00 and gave the company an "outperform" rating in a report on Friday, February 6th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $244.33.

Cardinal Health News Roundup

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Raised and narrowed FY‑2026 non‑GAAP EPS guidance to $10.70–$10.80 (above Street consensus), signaling management confidence in specialty pharma demand. Cardinal Health lifts annual profit forecast on strong demand for specialty drugs — Reuters
• Positive Sentiment: Q3 non‑GAAP EPS beat — $3.17 vs. ~$2.80 consensus — and non‑GAAP operating earnings rose ~18%, showing margin improvement on pharma and specialty growth. Cardinal Health (CAH) Q3 Earnings Beat Estimates — Zacks
• Positive Sentiment: Returned capital and reduced leverage: completed an additional $250M buyback this quarter (bringing FY total to $1.0B), which supports EPS and buyback-driven shareholder returns. Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook — PR Newswire
• Neutral Sentiment: Earnings materials and call transcript are available for walk‑throughs of segment dynamics (pharma vs. Med/surg, specialty drug margins) for investors who want detail. Cardinal Health, Inc. (CAH) Q3 2026 Earnings Call Transcript — Seeking Alpha
• Neutral Sentiment: Analyst activity (e.g., new coverage/positive notes) and media pieces highlight differing views — some push the stock higher on guidance; others focus on the revenue miss. Cardinal Health Rises. A Guidance Hike Powers the Stock Past These Weak Points. — Barron's
• Negative Sentiment: Revenue missed expectations: Q3 sales ~$60.9B vs. ~$62.2B est., raising concerns about volume/price trends and muting the EPS beat. Cardinal Health is getting pummeled on mixed results — here's our plan for stock — CNBC
• Negative Sentiment: GAAP results were weaker: GAAP operating earnings and EPS fell (GAAP EPS down ~20%) after a $184M pre‑tax goodwill impairment in Navista & ION — a one‑time but visible hit to GAAP profitability. Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook — PR Newswire
• Negative Sentiment: Market reaction: despite the EPS beat and guidance raise, investors sold on mixed signals (top‑line miss + impairment), producing heavier volume and downward pressure. Why Is Cardinal Health Stock Sinking Thursday? — Benzinga

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.